SDBiotechInvestor Posted - 04/26/24

$IMMX CAR-T NXC-201 late breaking, oral presentation two weeks out. Previous data has been perfection (100% ORR in AL Amyloidosis). Similar to $GRCL, these guys will likely get bought out in next 12-18 months if this kind of data keeps up.

sunirg Posted - 1 month ago

@1LIFE2LIVE they already bought $GRCL so no chnace here

Quantumup Posted - 03/21/24

Stifel⬆️ $CABA $32 was $31/Buy~believes if CABA-201 looks in-line w/ other CAR T's, invs will gain > comfort around the IASO-procured CAR T's /Co's ability2generate high efficacy data in US pts; thinks CABA's weak because Co hasn't yet Tx'd an SLE pt. Co is clearly making progress in Myositis, and per Stifel's convo w/ Mgmt/r confident that they will have SLE data by 1H24. $grcl $autl $bmy $kytx nvs

Digital_Waffle_Pirate Posted - 2 months ago

$GRCL $KRON 🙏 thank you for the kind words - but keep scrolling tho, there’s some epic losers in there 🤣😂 After all, I’m just a breakfast food.

StockAuthority Posted - 2 months ago

$KRON know who you trade with this guy is a baller caller wow! 4 bagger caller biotech $GRCL 2.52 to 10.22 BUYOUT and now he’s saying he wants an 8 bagger from here on $KRON I’m adding more tomorrow now that I’ve scrolled his profile and seen his picks 😮 💰 😮

StockAuthority Posted - 2 months ago

$KRON this dude knows how to pick biotech winners he got a triple on this pick $GRCL and now he’s excited about another stock being slept on w only 540 watchers, ie $KRON

LabPsycho Posted - 2 months ago

$KRON @Digital_Waffle_Pirate Excellent comparison $GRCL

StockAuthority Posted - 2 months ago

$KRON is this the next $GRCL 2.0 that went up 650%??? Read the DD and decide for yourself!

GuerillaStockTrading Posted - 02/25/24

Advancing Cell Therapy for Lupus Treatment: A Promising Frontier $RNAC $GRCL $KYTX https://www.guerillastocktrading.com/advancing-cell-therapy-for-lupus-treatment-a-promising-frontier/

Ninja_Tradez Posted - 02/22/24

📢 $GRCL - Stifel Downgrades Gracell Biotechnologies to Hold, Lowers Price Target to $10.25 https://newsfilter.io/a/b44bbc4e88276819520a1f12d2519285

Stock_Titan Posted - 02/22/24

$GRCL Gracell Biotechnologies Acquisition Completed https://www.stocktitan.net/news/GRCL/gracell-biotechnologies-acquisition-sxjlblaufwci.html

tradethehalt Posted - 02/21/24

$GRCL trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $10.25 Vol: 6.42M.

HaltTradeAlert Posted - 02/21/24

$GRCL Halt Time: 19:50:00 Issue Symbol: GRCL Reason Code: T12 Stock Price: $10.25 Market Cap: 989.867M Volume: 6,373,187 Relative Volume: 4.61 Shares Float: 165.04M Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

CTFNLighthouse Posted - 02/20/24

$GRCL $AZN Gracell Biotechnologies shareholders approved the company’s proposed acquisition by AstraZeneca. The transaction is expected to close on or around February 22.

pepe7 Posted - 02/20/24

$GRCL

Stock_Titan Posted - 02/20/24

$GRCL Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement https://www.stocktitan.net/news/GRCL/gracell-biotechnologies-announces-shareholders-approval-of-merger-q6cd5rk333w8.html

Noobnioo Posted - 02/15/24

$GRCL Buy Imab stock. Now is good buy position. Good luck. 🍀

Noobnioo Posted - 02/14/24

$IMAB As I wrote yesterday, $GRCL is falling. Imab shares must be bought. I hope it starts. 🍀😉

Noobnioo Posted - 02/13/24

$IMAB Imab shares should be bought now. Jump up 30% The other shares ($GRCL and $VTLE) underperform.

TeresaTrades Posted - 02/12/24

Largest PUT OI increases $KVUE $PSEC $WBD $GRCL $PINS

TurboWago Posted - 2 months ago

$GRCL eyeing sept 20, 2024 $12.50 calls, if the buy out happens wouldn’t share price be higher then $12.50? Calls at $0.15 break even $12.65 and buyout was about a 20%+ premium?

TalkMarkets Posted - 3 months ago

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets $SNY $HCM $GRCL https://talkmarkets.com/content/global-markets/week-in-review-shanghai-inmagene-signs-230-million-deal-to-develop-two-hutchmed-immunology-assets?post=430414&userid=123969

stang882 Posted - 01/30/24

$GRCL has anyone deciphered what we actually get if we just hold shares until after the merger is complete?

DonCorleone77 Posted - 01/29/24

$GRCL 2 of 2 - Gracell announces FDA clearance of IND application for Phase 1 trial of GC012F ...."This IND marks an exciting milestone as we extend efforts to address significant unmet needs earlier in multiple myeloma treatment through GC012F's unique dual-targeting approach and FasTCAR manufacturing, which have already shown great promise for deeper, durable responses. It also clears the path toward generating safety and efficacy data specifically in ELMM patients, providing us with the opportunity to better explore and define GC012F's potential role across this initial treatment setting where there is a deep need to drive improved, sustained outcomes."

DonCorleone77 Posted - 01/29/24

$GRCL 1 of 2 - Gracell announces FDA clearance of IND application for Phase 1 trial of GC012F Gracell Biotechnologies announced that the U.S. Food and Drug Administration, FDA, has cleared Gracell's Investigational New Drug, IND, application, allowing the Company to initiate a Phase 1 clinical trial of GC012F in the United States for the early-line treatment of multiple myeloma, ELMM. "We are extremely pleased to receive our third U.S. IND clearance for our lead FasTCAR candidate GC012F, now expanding company-sponsored investigation into early-line multiple myeloma," said Dr. William Cao, founder, Chairman and Chief Executive Officer of Gracell....

TeresaTrades Posted - 01/25/24

Heavy options volume $AMSC $IFF $ENTG $RC $GRCL

InsiderFinance Posted - 01/24/24

🚨 Heavy institutional volume on $GRCL! Options trading 5.4x the daily average, ranking 3 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $GRCL - Momentum Rank: 3 - Volume Surge: 5.4x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

InsiderFinance Posted - 01/23/24

🚨 Heavy institutional volume on $GRCL! Options trading 5.4x the daily average, ranking 3 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $GRCL - Momentum Rank: 3 - Volume Surge: 5.4x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

TrendyChart Posted - 01/22/24

$GRCL Technical patterns on the stock chart paint a picture of potential prosperity, with support levels bolstering its foundation. 🚀 https://thetrendychart.com/

TheOriginalBagHolder Posted - 01/18/24

$THMO I didn't know $AZN will acquire $GRCL for $1.2B. https://www.reuters.com/markets/deals/aztrazeneca-buy-china-based-gracell-biotechnologies-12-bln-deal-2023-12-26/ $GRCL is a real company with real CAR-T pipeline and manufacturing process. "AstraZeneca said in a statement that Gracell’s technology would complement the company’s existing work in cell therapy and was an “opportunity to bring a potential best-in-class treatment to patients living with blood cancers using a differentiated manufacturing process, as well as exploring the potential for cell therapy to reset the immune response in autoimmune diseases”. "...using a differentiated manufacturing process..." I have to ask why no company in the entire world wants to acquire $THMO and its (supposed) 10,000 doses/year mftg capacity and its (supposed) CAR-TXpress platform and its (supposed) "expertise". The world is facing a shortage of manufacturing capacity. You have a company that's capable of manufacturing 10K doses/year and nothing happens. I find that really hard to believe.